Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hester Biosciences Limited ( (IN:HESTERBIO) ) has shared an update.
Hester Biosciences has announced the resignation of non-executive director Ravin Gandhi, effective 12 May 2026, after he cited ongoing professional and personal commitments that prevent him from devoting sufficient time to board duties and company affairs. The company stated that Gandhi confirmed there were no other material reasons for his departure, and his exit underscores a routine board-level change rather than a governance dispute.
As a result of his resignation, alternate director Nina Gandhi has automatically ceased to hold office from the same date, in line with her role being tied to his board position. The company has notified the stock exchanges under SEBI’s disclosure rules, signaling compliance with listing obligations while stakeholders monitor any future moves to fill the non-executive board vacancy and maintain board continuity.
More about Hester Biosciences Limited
Hester Biosciences Limited operates in the biosciences and pharmaceutical sector, focusing on health-related products and services, and is listed on both BSE and the National Stock Exchange under the symbol HESTERBIO. The company adheres to Indian securities regulations governing listed entities, including disclosure and reporting obligations to stock exchanges.
Average Trading Volume: 407
Technical Sentiment Signal: Hold
Current Market Cap: 14.03B INR
Find detailed analytics on HESTERBIO stock on TipRanks’ Stock Analysis page.